Characteristics (mean ± SD or n(%)) | Total (n = 410) | Unweighted | Greedy matching | Stabilized IPTW | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Tofacitinib | Adalimumab | SMD | Tofacitinib | Adalimumab | SMD | Tofacitinib | Adalimumab | SMD | ||
(n = 281) | (n = 129) | (n = 139) | (n = 92) | (n = 226) | (n = 99) | |||||
Age | 53.52 ± 12.19 | 54.47 ± 12.10 | 51.45 ± 12.18 | 0.249 | 52.73 ± 11.81 | 51.32 ± 11.50 | 0.121 | 53.56 ± 12.48 | 53.27 ± 11.35 | 0.025 |
Sex | ||||||||||
 Male | 54 (13.17) | 40 (14.24) | 14 (10.85) | 0.102 | 16 (11.51) | 8 (8.70) | 0.094 | 28 (12.49) | 15 (15.44) | 0.085 |
 Female | 356 (86.83) | 241 (85.77) | 115 (89.15) | 123 (88.49) | 84 (91.30) | 197 (87.51) | 82 (84.56) | |||
Education | ||||||||||
  ≤ high school | 279 (67.89) | 194 (69.04) | 85 (65.89) | 0.067 | 94 (67.63) | 61 (66.3) | 0.028 | 153 (67.98) | 65 (67.55) | 0.009 |
 College or more ≤  | 131 (32.11) | 87 (30.96) | 44 (34.11) | 45 (32.37) | 31 (33.7) | 72 (32.03) | 31 (32.45) | |||
House annual incomea (10,000 won)b | ||||||||||
  < 5000 | 277 (67.89) | 191 (68.46) | 86 (66.67) | 0.038 | 94 (67.63) | 66 (71.74) | 0.090 | 153 (67.72) | 69 (71.26) | 0.077 |
 5000 ≤  | 131 (32.11) | 88 (31.54) | 43 (33.33) | 45 (32.37) | 26 (28.26) | 73 (32.28) | 28 (28.74) | |||
Employment | ||||||||||
 Employed | 178 (45.64) | 122 (46.04) | 56 (44.8) | 0.025 | 67 (48.2) | 45 (48.91) | 0.014 | 104 (45.89) | 47 (48.41) | 0.050 |
 Unemployed | 212 (54.36) | 143 (53.96) | 69 (55.2) | 72 (51.8) | 47 (51.09) | 122 (54.11) | 50 (51.59) | |||
BMI | 23.43 ± 3.56 | 23.56 ± 3.54 | 23.13 ± 3.60 | 0.118 | 23.55 ± 3.52 | 23.30 ± 3.78 | 0.068 | 23.57 ± 3.58 | 23.56 ± 3.89 | 0.001 |